ArticleThe journal of nutrition, health & aging2026
Biological age acceleration, genetic susceptibility, and incident diabetic retinopathy risk: A prospective cohort study.
Article in The journal of nutrition, health & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic retinopathy (DR) remains a major microvascular complication of diabetes, and conventional risk factors do not fully explain individual differences in disease risk. This study investigated the associations of biological age acceleration with incident DR.
methodsThis prospective cohort study included 12,608 UK Biobank participants with diabetes. Three biological age acceleration measures, including phenotypic age acceleration (PhenoAgeAccel), Klemera-Doubal method Biological Age acceleration (KDMAccel), and Gompertz Law-Based Biological Age difference (GOLD BioAgeDiff), were evaluated. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident DR. Joint effects with polygenic risk score were further assessed. Analyses were also repeated in the general population.
resultsHigher biological age acceleration was consistently associated with an increased risk of incident DR. Per 5-year increase, the fully adjusted HRs were 1.32 (95% CI, 1.26-1.38) for PhenoAgeAccel, 1.13 (95% CI, 1.11-1.16) for KDMAccel, and 1.20 (95% CI, 1.16-1.24) for GOLD BioAgeDiff. Participants with both high genetic risk and accelerated biological aging had the highest risk of DR, and additive interaction was observed between biological age acceleration and genetic susceptibility. Similar patterns were observed in the general population.
conclusionThe results suggest that accelerated biological aging is associated with a higher risk of incident DR and may have potential relevance for DR risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.